Home/Pipeline/PROphetNSCLC

PROphetNSCLC

Non‑Small‑Cell Lung Cancer

CommercialActive

Key Facts

Indication

Non‑Small‑Cell Lung Cancer

Phase

Commercial

Status

Active

Company

About OncoHost

AI‑driven plasma proteomics platform that predicts immunotherapy response for oncology patients.

View full company profile

Therapeutic Areas

Oncology Immunotherapy